Development and economic trends in cancer therapeutic drugs: a 5-year update 2010–2014


Background:Over the past 20 years, the mechanisms of action, duration of benefits and economic costs of newly licenced cancer drugs have changed significantly; however, summary data on these characteristics are limited.Methods:In this study, using historical copies of the British National Formulary and relevant contemporary publications, we have documented… (More)
DOI: 10.1038/bjc.2015.56

5 Figures and Tables


  • Presentations referencing similar topics